Dextran-based coacervate nanodroplets as potential gene carriers for efficient cancer therapy

Publication date: Available online 29 November 2019Source: Carbohydrate PolymersAuthor(s): Wang Chenglong, Xiong Shuhan, You Jiayi, Guan Wencai, Xu Guoxiong, Dou HongjingAbstractThe intractable toxicity of cationic polymers limits their applicability in gene transport and controlled release. In consideration of the good biocompatibility and biofunctionality of dextran, herein we design and synthesize two types of amino group-containing cationic copolymers based on dextran by the copolymerization of cationic monomers from dextran backbones. Additionally, allyl crosslinkers containing disulfide bonds were introduced into polymerization, that made the copolymer crosslinked by disulfide. The resultant coacervates were formed from the self-assembly of cationic coplymers and anionic genes, and redox-responsive disulfide branch points endow coacervates with reducing environment responsiveness. The in vitro experiments showed that the dextran-based coacervates were sensitive to the reducing environment and underwent cleavage, which resulted in an effective release, uptake, and transfection of the genes by 293T cells. In addition, dextran-based coacervates can be used to carry siRNA into cancer cells with a high transfection efficiency, demonstrating their potential applicability in treatment against cancer.
Source: Carbohydrate Polymers - Category: Biomedical Science Source Type: research